ICD10 code of Sweet Syndrome and ICD9 code

The medical classification for Sweet Syndrome, also known as acute febrile neutrophilic dermatosis, is identified by the ICD-10 code L98.2. Under the older ICD-9-CM classification system, Sweet Syndrome was categorized under the code 695.89.

What is the clinical presentation of Sweet Syndrome?

Sweet Syndrome typically manifests as the sudden onset of painful, erythematous, edematous plaques or nodules, most commonly appearing on the face, neck, and upper extremities. Patients often experience systemic symptoms, including high fever and an elevated white blood cell count (neutrophilia). Because Sweet Syndrome is frequently reactive, clinicians often investigate underlying triggers, such as infections, malignancies (particularly acute myeloid leukemia), or medications.

How is Sweet Syndrome diagnosed?

Diagnosis of Sweet Syndrome is primarily clinical and histological. Physicians typically utilize the Su criteria to confirm a diagnosis, which involves meeting both major criteria and at least two minor criteria. The diagnostic process generally includes:

• A skin biopsy showing dense neutrophilic infiltration in the upper dermis.


• Laboratory blood work, such as a Complete Blood Count (CBC) to identify neutrophilia.


• Exclusion of infectious causes through cultures.


• Evaluation for underlying systemic conditions or paraneoplastic markers.

What is the prognosis and management for Sweet Syndrome?

For the 73 members of our Sweet Syndrome community at DiseaseMaps.org, understanding the treatment path is vital. Sweet Syndrome is usually highly responsive to systemic corticosteroids, which remain the first-line therapy. While the skin lesions of Sweet Syndrome often resolve rapidly, recurrences can occur, necessitating long-term monitoring by a dermatologist or rheumatologist.

Is Sweet Syndrome hereditary?

Sweet Syndrome is generally not considered an inherited genetic condition. It is classified as an inflammatory skin disorder often triggered by external factors or internal systemic dysregulation. Current research into Sweet Syndrome focuses on the cytokine-mediated inflammatory response rather than hereditary transmission patterns.

Next steps

• Consult with a board-certified dermatologist or rheumatologist to discuss management strategies.


• Maintain a symptom diary to track potential triggers or medication side effects.


• Connect with the 73 peers at DiseaseMaps.org to share experiences and coping strategies.


• Request a referral to a center of excellence if your case of Sweet Syndrome is refractory to standard steroid therapy.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the guidance of your physician with any questions regarding your medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Sweet Syndrome.


• Orphanet (ORPHA: 3207): Acute febrile neutrophilic dermatosis.


• OMIM (Online Mendelian Inheritance in Man): Entry #608068.


• American Academy of Dermatology (AAD): Neutrophilic Dermatoses Guidelines.